Curi Bio
Curi Bio provides integrated platforms that combine advanced 3D human tissue models, biosystems for functional analysis, and AI-enabled data analytics to support drug discovery and preclinical R&D. Its products and services are used by pharmaceutical and biotechnology companies to improve the predictive accuracy of drug safety, efficacy, and potency assessments, with a focus on cardiac, skeletal muscle, and disease models. The organization aims to accelerate the development of next-generation human medicines by integrating human cells, systems, and data.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2015
- Type
- Corporation Seattle business license
- Employees
- 51
- Registered name
- Nanosurface Biomedical Inc Seattle business license
- Stage
- Series B
- Founders
- Elliot Fisher
Is this your organization? Claim it
Developer Builds Crewbird CRM to Integrate Google Local Service Ads and Boost Dad’s Carpet-Cleaning Business to Nearly 3x ROAS
A laid-off developer built Crewbird, a field service management CRM that integrates Google Local Service Ads to consolidate disparate health and service data and help his dad’s carpet-cleaning business nearly triple its ROAS, while noting gaps between ERPs and simple spreadsheets for service businesses.
Curi Bio Expands Curiverse with Disease-Specific iPSC Models, Casting Kits, and Assays for Cardiac, Skeletal Muscle, and Neuromuscular Research
Curi Bio expanded its Curiverse ecosystem to offer disease-specific iPSC models, casting kits, validated assays, and integrated research services for cardiac, skeletal muscle, and neuromuscular applications, enabling researchers to accelerate human-relevant drug discovery without building models in-house.
Justin Lee and Changho Chun Found NuukBio Inc. to Advance iPSC-Based Disease Models and Drug Discovery
Two researchers who met in 2016 bonded over using human stem cells for disease modeling and drug screening, and after training in ISCRM labs they co-founded NuukBio Inc. in late 2025 to build more physiologically relevant iPSC-based models for drug discovery.
See all 11 stories, episodes and videos about Curi Bio.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Elliot Fisher Co-Founder & Chief Business Officer
-
Michael Cho Executive, Chief Strategy Officer
-
Nicholas Geisse Executive, Chief Executive Officer